G49N.STU Gensight Biologics SA

- EUR
Market cap
-
P/E
-
P/B
30.78x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is G49N.STU undervalued?

Graham number

The Graham number of Gensight Biologics SA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Gensight Biologics SA fundamental analysis

No fundamental analysis for Gensight Biologics SA yet.

Gensight Biologics SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.